SCHEMBL278935

SCHEMBL278935

CCCCOCC(COCC)(COCC)COCCCC

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.42
CES1 P23141 1/20 0.41
CYP3A4 P08684 2/20 0.37
ADRB2 P07550 1/20 0.36
ADRB1 P08588 1/20 0.36
ADRB3 P13945 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
HPGD P15428 1/20 0.35
MEN1 O00255 1/20 0.33
THRB P10828 1/20 0.33
HTT P42858 1/20 0.33
KMT2A Q03164 1/20 0.33
MAPT P10636 1/20 0.33
CES2 O00748 2/20 0.32
ALDH1A1 P00352 2/20 0.31
CA1 P00915 1/20 0.30
CA2 P00918 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL278852 1.00 TSHR (0.42) TSHRCES1CYP3A4ADRB2ADRB1
SCHEMBL278793 1.00 TSHR (0.42) TSHRCES1CYP3A4ADRB2ADRB1
SCHEMBL278799 0.92 TSHR (0.48) TSHRCES1CYP3A4ADRB2ADRB1
SCHEMBL18378988 0.90 TSHR (0.46) TSHRCES1CYP3A4ADRB2ADRB1
SCHEMBL12047455 0.89 TSHR (0.50) TSHRCES1CYP3A4SMN1; SMN2MEN1
SCHEMBL12047458 0.89 TSHR (0.50) TSHRCES1CYP3A4SMN1; SMN2MEN1
SCHEMBL19792791 0.87 TSHR (0.50) TSHRCES1CYP3A4ADRB2ADRB1
SCHEMBL17775385 0.87 CES1 (0.52) TSHRCES1CYP3A4ADRB2ADRB1
SCHEMBL14616850 0.84 HSD17B10 (0.33) CES1THRBALDH1A1
SCHEMBL14616849 0.84 HSD17B10 (0.33) CES1THRBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8133707-B2 Methods of preparing activated polymers having alpha nitrogen groups ENZON PHARMACEUTICALS, INC. (US) 2012-03-13 US disclosed
US-20070166808-A1 Methods of preparing activated polymers having alpha nitrogen groups BELROSE PHARMA INC. 2007-07-19 US disclosed